Pediatrician Office Treatment for Childhood Obesity Proves Effective

Childhood obesity remains a stubborn public-health challenge in the United States, affecting roughly one in five children, yet specialized pediatric weight-management resources are still out of reach for many families. A new large-scale clinical trial suggests that a proven family-based behavioral program can be delivered effectively in routine primary care—an important shift toward scalable, real-world obesity treatment.

The study, published July 27 in JAMA Pediatrics, drew on data from more than 700 children with obesity across four states and 41 primary care practices. Researchers evaluated outcomes in a randomized pragmatic design, comparing enhanced usual care with an added family-centered behavioral intervention.

Participants were children aged 6 to 15, randomly assigned to either enhanced standard of care or enhanced standard of care plus up to 33 sessions with a trained interventionist. Sessions were designed for the child and a parent to learn skills together: monitoring eating and activity, setting measurable goals, modifying the home environment, and reinforcing progress through positive feedback and parental modeling.

On average, families attended about 17 sessions rather than the full complement, yet the intervention still produced clinically meaningful weight improvements for many participants. Nearly half of children in the family-based program achieved weight reductions associated with improved heart and metabolic health, with benefits persisting at an 18-month follow-up.

The momentum mattered. Although both groups started at about 77% above a healthy weight range, children receiving the family-based treatment declined further to roughly 70% after one year, compared with about 74% in the enhanced care group. By the follow-up point, around 42% of families in the intervention arm reached a clinically relevant level of weight loss—at about 1.5 times the rate of children receiving enhanced care alone.

Parents also reported broader improvements, including better weight-related quality of life for children and enhanced household nutrition and activity routines. This emphasis on family dynamics is central to how the program sustains behavior change beyond supervised visits.

A notable implementation detail strengthened the trial’s relevance: because much of the study coincided with COVID-19, over 75% of sessions occurred via telehealth. Outcomes were comparable to those achieved with in-person delivery, underscoring the model’s flexibility for reducing access barriers.

The program was built to fit within everyday clinical workflows and was designed to be billable by primary care providers and behavioral interventionists, including care teams already operating in participating practices. Importantly, the trial included populations often excluded from efficacy-only studies, including families facing food insecurity and common comorbid conditions.

Looking ahead, the investigators plan longer-term follow-up at five and 10 years to determine how durable these gains remain as children grow and treatment needs evolve.